Treace Medical Concepts (TMCI) Equity Average (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Equity Average data on file, last reported at $82.3 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 24.61% year-over-year to $82.3 million; the trailing twelve-month figure through Mar 2026 stood at $82.3 million (down 24.61% YoY), and the FY2025 full-year result was $100.1 million, down 20.18% from the prior year.
• Equity Average for Q1 2026 stood at $82.3 million, down from $88.3 million in the prior quarter.
• Across five years, Equity Average topped out at $153.8 million in Q2 2023 and bottomed at $61.4 million in Q4 2022.
• The 5-year median for Equity Average is $108.5 million (2024), against an average of $105.0 million.
• Peak annual rise in Equity Average reached 195433.7% in 2022, while the deepest fall reached 35.56% in 2022.
• A 5-year view of Equity Average shows it stood at $61.4 million in 2022, then surged by 124.72% to $137.9 million in 2023, then decreased by 21.03% to $108.9 million in 2024, then decreased by 18.95% to $88.3 million in 2025, then slipped by 6.8% to $82.3 million in 2026.
• The last three Equity Average figures came in at $82.3 million (Q1 2026), $88.3 million (Q4 2025), and $93.4 million (Q3 2025), per Business Quant data.

Peer Comparison